Uj diagnosztikai lehetöségek a börgyógyászati kórképekben.

Translated title of the contribution: New diagnostic possibilities in dermatologic diseases

Research output: Contribution to journalArticle

Abstract

The author reviews the latest developments regarding the most important immunological methods for the diagnosis of dermatological diseases. The salt-split-skin, fluorescence overlay antigen mapping and immunoblot techniques are useful methods for the differentiation of autoimmune bullous skin diseases. The use of recombinant fusion products of antigenic epitopes in patients with pemphigus and bullous pemphigoid affords a possibility for the differentiation or diagnosis of the disease by means of a simple ELISA technique. In situ hybridization and the polymerase chain reaction (PCR) technique are very useful in many dermatological diseases to demonstrate infective agents or genetic abnormalities.

Original languageHungarian
Pages (from-to)2167-2171
Number of pages5
JournalOrvosi Hetilap
Volume140
Issue number39
Publication statusPublished - Sep 26 1999

Fingerprint

Vesiculobullous Skin Diseases
Bullous Pemphigoid
Immunologic Tests
Pemphigus
In Situ Hybridization
Epitopes
Salts
Fluorescence
Enzyme-Linked Immunosorbent Assay
Antigens
Polymerase Chain Reaction
Skin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Uj diagnosztikai lehetöségek a börgyógyászati kórképekben. / Husz, S.

In: Orvosi Hetilap, Vol. 140, No. 39, 26.09.1999, p. 2167-2171.

Research output: Contribution to journalArticle

@article{991ca8597da14a9a9500bc57807bc929,
title = "Uj diagnosztikai lehet{\"o}s{\'e}gek a b{\"o}rgy{\'o}gy{\'a}szati k{\'o}rk{\'e}pekben.",
abstract = "The author reviews the latest developments regarding the most important immunological methods for the diagnosis of dermatological diseases. The salt-split-skin, fluorescence overlay antigen mapping and immunoblot techniques are useful methods for the differentiation of autoimmune bullous skin diseases. The use of recombinant fusion products of antigenic epitopes in patients with pemphigus and bullous pemphigoid affords a possibility for the differentiation or diagnosis of the disease by means of a simple ELISA technique. In situ hybridization and the polymerase chain reaction (PCR) technique are very useful in many dermatological diseases to demonstrate infective agents or genetic abnormalities.",
author = "S. Husz",
year = "1999",
month = "9",
day = "26",
language = "Hungarian",
volume = "140",
pages = "2167--2171",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "39",

}

TY - JOUR

T1 - Uj diagnosztikai lehetöségek a börgyógyászati kórképekben.

AU - Husz, S.

PY - 1999/9/26

Y1 - 1999/9/26

N2 - The author reviews the latest developments regarding the most important immunological methods for the diagnosis of dermatological diseases. The salt-split-skin, fluorescence overlay antigen mapping and immunoblot techniques are useful methods for the differentiation of autoimmune bullous skin diseases. The use of recombinant fusion products of antigenic epitopes in patients with pemphigus and bullous pemphigoid affords a possibility for the differentiation or diagnosis of the disease by means of a simple ELISA technique. In situ hybridization and the polymerase chain reaction (PCR) technique are very useful in many dermatological diseases to demonstrate infective agents or genetic abnormalities.

AB - The author reviews the latest developments regarding the most important immunological methods for the diagnosis of dermatological diseases. The salt-split-skin, fluorescence overlay antigen mapping and immunoblot techniques are useful methods for the differentiation of autoimmune bullous skin diseases. The use of recombinant fusion products of antigenic epitopes in patients with pemphigus and bullous pemphigoid affords a possibility for the differentiation or diagnosis of the disease by means of a simple ELISA technique. In situ hybridization and the polymerase chain reaction (PCR) technique are very useful in many dermatological diseases to demonstrate infective agents or genetic abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=17944398088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944398088&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 2167

EP - 2171

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 39

ER -